Ventyx Biosciences Inc.

NASDAQ: VTYX · Real-Time Price · USD
2.85
-0.15 (-5.00%)
At close: Aug 15, 2025, 3:59 PM
2.88
1.18%
After-hours: Aug 15, 2025, 06:58 PM EDT

Ventyx Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
27.26M 51.58M 64.82M 70.79M
Short-Term Investments
190.06M 200.64M 253.12M 187.78M
Long-Term Investments
35.62M n/a 38.67M 28.15M
Other Long-Term Assets
1.03M 1.08M 96K 60K
Receivables
1M 800K n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
11.3M 11.32M 12.75M n/a
Total Current Assets
229.63M 264.35M 330.69M 263.02M
Property-Plant & Equipment
10.28M 12.27M 1.94M 254K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
46.94M 13.35M 40.71M 28.46M
Total Assets
276.56M 277.69M 371.4M 291.48M
Account Payables
3.13M 5.76M 6.43M 4.66M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.05M 1M 412K n/a
Other Current Liabilities
-1.05M -1M 4.89M n/a
Total Current Liabilities
12.78M 22.27M 16.36M 12.28M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
9.74M 11.51M 1.15M 4.66M
Total Liabilities
22.52M 33.77M 17.5M 12.28M
Total Debt
10.79M 12.51M 1.56M n/a
Common Stock
7K 6K 6K 5K
Retained Earnings
-554.31M -419.19M -226.22M -117.8M
Comprehensive Income
157K -50K -1.12M -58K
Shareholders Equity
254.04M 243.92M 353.89M 279.2M
Total Investments
225.68M 200.64M 291.79M 215.93M